Trine Bay Laurbjerg

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Inge Christoffer Olsen, J. Lampa, M. Nurmohamed, 2023, Annals of the Rheumatic Diseases.